Risk stratification and epidemiology of sudden death

Sri Sundaram, Jeffrey Goldberger

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Recent data from the Centers for Disease Control and Prevention show that sudden cardiac death accounts for approximately 400,000 deaths annually in this country. The survival rate for these patients is dismal. Because of the low probability of survival from a cardiac arrest, there has been an increasing focus on primary prevention. The implantable cardioverter defibrillator (ICD) is a highly effective treatment to abort potentially fatal arrhythmic episodes. Thus, various trials have been conducted to determine methods to best identify patients at high risk for sudden arrhythmic death. This review focuses on the epidemiology of sudden cardiac death and risk stratification approaches that have been tested to determine whether they can identify populations likely to benefit from an ICD.

Original languageEnglish (US)
Pages (from-to)333-338
Number of pages6
JournalCurrent Cardiology Reports
Volume6
Issue number5
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Sudden Death
Epidemiology
Primary Prevention
Centers for Disease Control and Prevention (U.S.)
Heart Arrest
Survival Rate
Survival
Population
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Risk stratification and epidemiology of sudden death. / Sundaram, Sri; Goldberger, Jeffrey.

In: Current Cardiology Reports, Vol. 6, No. 5, 01.01.2004, p. 333-338.

Research output: Contribution to journalReview article

@article{2b9d989c019e46d9a4410681df6f983d,
title = "Risk stratification and epidemiology of sudden death",
abstract = "Recent data from the Centers for Disease Control and Prevention show that sudden cardiac death accounts for approximately 400,000 deaths annually in this country. The survival rate for these patients is dismal. Because of the low probability of survival from a cardiac arrest, there has been an increasing focus on primary prevention. The implantable cardioverter defibrillator (ICD) is a highly effective treatment to abort potentially fatal arrhythmic episodes. Thus, various trials have been conducted to determine methods to best identify patients at high risk for sudden arrhythmic death. This review focuses on the epidemiology of sudden cardiac death and risk stratification approaches that have been tested to determine whether they can identify populations likely to benefit from an ICD.",
author = "Sri Sundaram and Jeffrey Goldberger",
year = "2004",
month = "1",
day = "1",
doi = "10.1007/s11886-004-0035-6",
language = "English (US)",
volume = "6",
pages = "333--338",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "5",

}

TY - JOUR

T1 - Risk stratification and epidemiology of sudden death

AU - Sundaram, Sri

AU - Goldberger, Jeffrey

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Recent data from the Centers for Disease Control and Prevention show that sudden cardiac death accounts for approximately 400,000 deaths annually in this country. The survival rate for these patients is dismal. Because of the low probability of survival from a cardiac arrest, there has been an increasing focus on primary prevention. The implantable cardioverter defibrillator (ICD) is a highly effective treatment to abort potentially fatal arrhythmic episodes. Thus, various trials have been conducted to determine methods to best identify patients at high risk for sudden arrhythmic death. This review focuses on the epidemiology of sudden cardiac death and risk stratification approaches that have been tested to determine whether they can identify populations likely to benefit from an ICD.

AB - Recent data from the Centers for Disease Control and Prevention show that sudden cardiac death accounts for approximately 400,000 deaths annually in this country. The survival rate for these patients is dismal. Because of the low probability of survival from a cardiac arrest, there has been an increasing focus on primary prevention. The implantable cardioverter defibrillator (ICD) is a highly effective treatment to abort potentially fatal arrhythmic episodes. Thus, various trials have been conducted to determine methods to best identify patients at high risk for sudden arrhythmic death. This review focuses on the epidemiology of sudden cardiac death and risk stratification approaches that have been tested to determine whether they can identify populations likely to benefit from an ICD.

UR - http://www.scopus.com/inward/record.url?scp=4544358006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544358006&partnerID=8YFLogxK

U2 - 10.1007/s11886-004-0035-6

DO - 10.1007/s11886-004-0035-6

M3 - Review article

VL - 6

SP - 333

EP - 338

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 5

ER -